Thu, August 15, 2024

Gena Wang Maintained (BLUE) at Buy with Decreased Target to $4 on, Aug 15th, 2024

Gena Wang of Barclays, Maintained "bluebird bio, Inc." (BLUE) at Buy with Decreased Target from $8 to $4 on, Aug 15th, 2024.

Gena, nor any peers, have made any analyst calls on BLUE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30